pyrazines has been researched along with Astrocytoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, D; Curran, WJ; Dicker, AP; Kubicek, GJ; Machtay, M; Mallon, G; Myers, T; Ramirez, M; Werner-Wasik, M | 1 |
Ahnert, P; Bauer, M; Ganten, TM; Haas, TL; Holland, H; Koschny, R; Krupp, W; Meixensberger, J; Sprick, MR; Sykora, J; Walczak, H | 1 |
Kyritsis, AP; Puduvalli, VK; Rao, JS; Tachmazoglou, F | 1 |
1 trial(s) available for pyrazines and Astrocytoma
Article | Year |
---|---|
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Boronic Acids; Bortezomib; Central Nervous System Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Glioblastoma; Humans; Male; Middle Aged; Pyrazines; Radiotherapy; Temozolomide; Treatment Outcome | 2009 |
2 other study(ies) available for pyrazines and Astrocytoma
Article | Year |
---|---|
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Topics: Adolescent; Adult; Aged; Apoptosis; Astrocytoma; Boronic Acids; Bortezomib; Brain Neoplasms; CASP8 and FADD-Like Apoptosis Regulating Protein; Down-Regulation; Female; Humans; Immunotherapy; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Pyrazines; TNF-Related Apoptosis-Inducing Ligand | 2007 |
Bortezomib sensitizes human astrocytoma cells to tumor necrosis factor related apoptosis-inducing ligand induced apoptosis.
Topics: Apoptosis; Astrocytoma; Boronic Acids; Bortezomib; Brain Neoplasms; CASP8 and FADD-Like Apoptosis Regulating Protein; Humans; Immunotherapy; Proto-Oncogene Proteins c-bcl-2; Pyrazines; TNF-Related Apoptosis-Inducing Ligand | 2007 |